Laboratorios Farmaceuticos ROVI SA
MAD:ROVI

Watchlist Manager
Laboratorios Farmaceuticos ROVI SA Logo
Laboratorios Farmaceuticos ROVI SA
MAD:ROVI
Watchlist
Price: 63 EUR 1.86% Market Closed
Market Cap: 3.2B EUR
Have any thoughts about
Laboratorios Farmaceuticos ROVI SA?
Write Note

Intrinsic Value

The intrinsic value of one ROVI stock under the Base Case scenario is 83.93 EUR. Compared to the current market price of 63 EUR, Laboratorios Farmaceuticos ROVI SA is Undervalued by 25%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ROVI Intrinsic Value
83.93 EUR
Undervaluation 25%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Laboratorios Farmaceuticos ROVI SA

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for ROVI cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about ROVI?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Laboratorios Farmaceuticos ROVI SA

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Laboratorios Farmaceuticos ROVI SA

Provide an overview of the primary business activities
of Laboratorios Farmaceuticos ROVI SA.

What unique competitive advantages
does Laboratorios Farmaceuticos ROVI SA hold over its rivals?

What risks and challenges
does Laboratorios Farmaceuticos ROVI SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Laboratorios Farmaceuticos ROVI SA.

Provide P/S
for Laboratorios Farmaceuticos ROVI SA.

Provide P/E
for Laboratorios Farmaceuticos ROVI SA.

Provide P/OCF
for Laboratorios Farmaceuticos ROVI SA.

Provide P/FCFE
for Laboratorios Farmaceuticos ROVI SA.

Provide P/B
for Laboratorios Farmaceuticos ROVI SA.

Provide EV/S
for Laboratorios Farmaceuticos ROVI SA.

Provide EV/GP
for Laboratorios Farmaceuticos ROVI SA.

Provide EV/EBITDA
for Laboratorios Farmaceuticos ROVI SA.

Provide EV/EBIT
for Laboratorios Farmaceuticos ROVI SA.

Provide EV/OCF
for Laboratorios Farmaceuticos ROVI SA.

Provide EV/FCFF
for Laboratorios Farmaceuticos ROVI SA.

Provide EV/IC
for Laboratorios Farmaceuticos ROVI SA.

Show me price targets
for Laboratorios Farmaceuticos ROVI SA made by professional analysts.

What are the Revenue projections
for Laboratorios Farmaceuticos ROVI SA?

How accurate were the past Revenue estimates
for Laboratorios Farmaceuticos ROVI SA?

What are the Net Income projections
for Laboratorios Farmaceuticos ROVI SA?

How accurate were the past Net Income estimates
for Laboratorios Farmaceuticos ROVI SA?

What are the EPS projections
for Laboratorios Farmaceuticos ROVI SA?

How accurate were the past EPS estimates
for Laboratorios Farmaceuticos ROVI SA?

What are the EBIT projections
for Laboratorios Farmaceuticos ROVI SA?

How accurate were the past EBIT estimates
for Laboratorios Farmaceuticos ROVI SA?

Compare the revenue forecasts
for Laboratorios Farmaceuticos ROVI SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Laboratorios Farmaceuticos ROVI SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Laboratorios Farmaceuticos ROVI SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Laboratorios Farmaceuticos ROVI SA compared to its peers.

Compare the P/E ratios
of Laboratorios Farmaceuticos ROVI SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Laboratorios Farmaceuticos ROVI SA with its peers.

Analyze the financial leverage
of Laboratorios Farmaceuticos ROVI SA compared to its main competitors.

Show all profitability ratios
for Laboratorios Farmaceuticos ROVI SA.

Provide ROE
for Laboratorios Farmaceuticos ROVI SA.

Provide ROA
for Laboratorios Farmaceuticos ROVI SA.

Provide ROIC
for Laboratorios Farmaceuticos ROVI SA.

Provide ROCE
for Laboratorios Farmaceuticos ROVI SA.

Provide Gross Margin
for Laboratorios Farmaceuticos ROVI SA.

Provide Operating Margin
for Laboratorios Farmaceuticos ROVI SA.

Provide Net Margin
for Laboratorios Farmaceuticos ROVI SA.

Provide FCF Margin
for Laboratorios Farmaceuticos ROVI SA.

Show all solvency ratios
for Laboratorios Farmaceuticos ROVI SA.

Provide D/E Ratio
for Laboratorios Farmaceuticos ROVI SA.

Provide D/A Ratio
for Laboratorios Farmaceuticos ROVI SA.

Provide Interest Coverage Ratio
for Laboratorios Farmaceuticos ROVI SA.

Provide Altman Z-Score Ratio
for Laboratorios Farmaceuticos ROVI SA.

Provide Quick Ratio
for Laboratorios Farmaceuticos ROVI SA.

Provide Current Ratio
for Laboratorios Farmaceuticos ROVI SA.

Provide Cash Ratio
for Laboratorios Farmaceuticos ROVI SA.

What is the historical Revenue growth
over the last 5 years for Laboratorios Farmaceuticos ROVI SA?

What is the historical Net Income growth
over the last 5 years for Laboratorios Farmaceuticos ROVI SA?

What is the current Free Cash Flow
of Laboratorios Farmaceuticos ROVI SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Laboratorios Farmaceuticos ROVI SA.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Laboratorios Farmaceuticos ROVI SA

Current Assets 540.8m
Cash & Short-Term Investments 44.6m
Receivables 136.6m
Other Current Assets 359.6m
Non-Current Assets 316.5m
Long-Term Investments 19.6m
PP&E 261.2m
Intangibles 33m
Other Non-Current Assets 2.7m
Current Liabilities 272.5m
Accounts Payable 80.9m
Accrued Liabilities 7.3m
Other Current Liabilities 184.3m
Non-Current Liabilities 108.8m
Long-Term Debt 98.1m
Other Non-Current Liabilities 10.6m
Efficiency

Earnings Waterfall
Laboratorios Farmaceuticos ROVI SA

Revenue
1B EUR
Cost of Revenue
-379.2m EUR
Gross Profit
634.1m EUR
Operating Expenses
-352.4m EUR
Operating Income
281.7m EUR
Other Expenses
-64.5m EUR
Net Income
217.2m EUR

Free Cash Flow Analysis
Laboratorios Farmaceuticos ROVI SA

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

ROVI Profitability Score
Profitability Due Diligence

Laboratorios Farmaceuticos ROVI SA's profitability score is 74/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Exceptional 3-Year Average ROIC
Positive Gross Profit
Exceptional ROE
74/100
Profitability
Score

Laboratorios Farmaceuticos ROVI SA's profitability score is 74/100. The higher the profitability score, the more profitable the company is.

ROVI Solvency Score
Solvency Due Diligence

Laboratorios Farmaceuticos ROVI SA's solvency score is 82/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Low D/E
Long-Term Solvency
82/100
Solvency
Score

Laboratorios Farmaceuticos ROVI SA's solvency score is 82/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ROVI Price Targets Summary
Laboratorios Farmaceuticos ROVI SA

Wall Street analysts forecast ROVI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ROVI is 96.27 EUR with a low forecast of 86.25 EUR and a high forecast of 109.2 EUR.

Lowest
Price Target
86.25 EUR
37% Upside
Average
Price Target
96.27 EUR
53% Upside
Highest
Price Target
109.2 EUR
73% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for ROVI?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for ROVI is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Laboratorios Farmaceuticos ROVI SA Logo
Laboratorios Farmaceuticos ROVI SA

Country

Spain

Industry

Pharmaceuticals

Market Cap

3.3B EUR

Dividend Yield

1.42%

Description

Laboratorios Farmaceúticos Rovi SA engages in the research, development, manufacture, and marketing of small molecule and specialty biologic drugs. The company is headquartered in Madrid, Madrid and currently employs 1,751 full-time employees. The company went IPO on 2007-10-26. The Company’s main activities include the development and commercialization, nationwide and abroad, of medicines and drugs. Its products are structured into three fields: Diagnostic, which offers contrast mediums for use in magnetic resonance, ultrasound and X-ray diagnostics; Prescription, which distributes medicines under such brands as Hibor, Osseor, Hepadren, Pneumovax-23, Glufan, Corlentor, Exxiv, Calcio y Vitamina D3 Rovi and Absorcol, among others; and Over The Counter (OTC), which comprises the Perspirex, Enerzona, Dentimelo and ColdPack brands. The firm owns such fully consolidated subsidiaries as Gineladius SL, Frosst Iberica SA, Rovi Contract Manufacturing SL and Bertex Pharma GmbH, among others.

Contact

MADRID
Madrid
C/ Julian Camarillo, 35
+34910213000.0
www.rovi.es

IPO

2007-10-26

Employees

1 751

Officers

Chairman & CEO
Mr. Juan Lopez-Belmonte Encina
Second Deputy Chairman & GM of Commercial and Development
Mr. Ivan Lopez-Belmonte Encina
First Deputy Chairman, GM of Industrial Operations & CFO
Mr. Javier Lopez-Belmonte Encina
Head of Investor Relations
Marta Campos Martínez
Legal Department Manager
Ms. Mercedes Benítez del Castillo Sánchez
Sales Manager
Ms. Beatriz Ávila Alcalde
Show More
Marketing Manager
Ms. Rosario Perucha Pérez
Human Resources Manager
Mr. Francisco Javier Angulo García
Secretary
Mr. Gabriel Nunez Fernandez
Show Less

See Also

Discover More
What is the Intrinsic Value of one ROVI stock?

The intrinsic value of one ROVI stock under the Base Case scenario is 83.93 EUR.

Is ROVI stock undervalued or overvalued?

Compared to the current market price of 63 EUR, Laboratorios Farmaceuticos ROVI SA is Undervalued by 25%.

Back to Top